Web-based Application to Test for Long-term Cognitive Deficits in BioCog Patients
NCT ID: NCT06716528
Last Updated: 2025-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
434 participants
OBSERVATIONAL
2025-01-07
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of Two Digital Devices for the Diagnosis of Neurocognitive Disorders in Elderly People With Cognitive Symptoms.
NCT06032611
Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease
NCT03672279
Biological Collection of Neurocognitive Disorders
NCT06244875
Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders
NCT01316562
Cognition and NeuroImaging in neuroDegenerative Disorders (CogNID)
NCT03861884
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* according to the International Statistical Classification of Diseases and Related Health Problems(ICD-10) classification system
* according to the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) classification system
* computer-based, online and independently conducted cognitive testing using Cantab Web based testing from Cambridge Cognition
* Cognitive self-care using Geriatric depression Scale item 10
* Cognitive self-care with Multifactorial Memory Questionnaire
* Cognitive other-care with The Informant Questionnaire on Cognitive Decline in the Elderly questionnaire
* Functionality with Activities of Daily Living (ADLs) \& Instrumental Activities of Daily Living (IADLs) questionnaire
* Additionally: Quality of life with 5-level EQ-5D version (EQ-5D-5L)
Evaluation by Mild Cognitive Impairment Algorithm of the University Clinic Bonn (research group Prof. Wagner).
Evaluation by mild/major Neurocognitive Disorder (NCD) algorithm of Charité - University Medicine Berlin (research group Prof. Spies)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Former BioCog patients
Former BioCog patients from the Berlin study center who have undergone baseline cognitive testing and from whom plasma samples are available
No interventions assigned to this group
Former BioCog subjects in the non-surgical comparison cohort
Former BioCog subjects in the non-surgical comparison cohort from the Berlin study center who have undergone baseline cognitive testing
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent for participation in the BioCog-Web study.
* Data and reserve samples from patients in the Berlin BioCog cohort who can no longer be contacted.
Exclusion Criteria
Subjects
Inclusion Criterion:
-BioCog subjects of the non-operated comparison cohort from Berlin with cognitive testing (CANTAB Research Suite) at baseline who are contactable
-None
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bonn
OTHER
University Hospital Schleswig-Holstein
OTHER
Universitätsklinikum Essen
OTHER
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudia Spies
Head of the Department of Anesthesiology and Intensive Care Medicine (CCM/CVK)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudia Spies, MD, Prof.
Role: PRINCIPAL_INVESTIGATOR
Charitè - University Berlin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Charité - University Medicine Berlin
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BioCog-Web
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.